← FDA Drug Approvals (Drugs@FDA)

IBUPROFEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMA CANADA · Approved 2017-06-27

Drug application

FDA Application #

ANDA209207

Application type

Abbreviated New Drug Application (Generic)

Brand name

IBUPROFEN

Generic name

IBUPROFEN

Active ingredients

IBUPROFEN

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Over-the-counter

Sponsor

SUN PHARMA CANADA

Manufacturer

Rite Aid Corporation

First approval

2017-06-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown